Literature DB >> 22885315

Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.

Manish Nagpal1, Vandana Tayal, Suresh Kumar, Usha Gupta.   

Abstract

OBJECTIVES: To identify the adverse drug reactions (ADRs) to antiretroviral therapy (ART) and to assess their impact on treatment compliance in patients with HIV/AIDS.
MATERIALS AND METHODS: Two hundred and thirty-five (235) AIDS patients who received ART were monitored for ADRs over a period of 6 months. The incidence and nature of ADRs occurring with different ART regimens were recorded. We also assessed the severity, causality as well as the impact of ADRs on the patients' compliance.
RESULTS: Of 235 patients receiving ART, 90.6% patients experienced ADRs. A total of 618 ADRs involving various systems were observed. A majority were related to gastrointestinal (42.39%) and central nervous (25.57%) system. 23.1% ADRs were severe in intensity. Severe ADRs occurred in 41 out of 235 (17.4%) patients necessitating drug withdrawal. A majority of the patients (87.8%) who complained of severe ADRs received combination of stavudine, lamivudine and nevirapine. Causality assessment revealed 6.63% ADRs were probable and 93.3% ADRs were possible. Non-compliance due to ADRs was observed in 28.9% patients.
CONCLUSIONS: Myriad ADRs are associated with ART which leads to poor patient compliance. With the increasing access to ART in India, it is prudent that antiretroviral drugs are used judicially with regular monitoring of ADRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22885315

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  13 in total

1.  Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 inhibitors.

Authors:  Brandon Putterill; Charles Rono; Banothile Makhubela; Debra Meyer; Ntombenhle Gama
Journal:  Biometals       Date:  2022-06-14       Impact factor: 3.378

2.  Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.

Authors:  H O Singh; S Lata; M Angadi; S Bapat; J Pawar; V Nema; M V Ghate; S Sahay; R R Gangakhedkar
Journal:  Pharmacogenomics J       Date:  2015-12-15       Impact factor: 3.550

3.  Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia.

Authors:  Woldesellassie M Bezabhe; Luke R Bereznicki; Leanne Chalmers; Peter Gee; Desalew M Kassie; Mekides A Bimirew; Gregory M Peterson
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.228

4.  Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.

Authors:  Wondmagegn Tamiru Tadesse; Alemayehu Berhane Mekonnen; Wubshet Hailu Tesfaye; Yidnekachew Tamiru Tadesse
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-23       Impact factor: 2.483

5.  Evaluation of adverse drug reactions in HIV positive patients in a tertiary care hospital.

Authors:  Anshu Kumar Jha; Akash Gadgade; Ashok K Shenoy; Mukta N Chowta; John T Ramapuram
Journal:  Perspect Clin Res       Date:  2015 Jan-Mar

6.  Adverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in Ghana.

Authors:  Margaret Lartey; Abena Asante-Quashie; Ama Essel; Ernest Kenu; Vincent Ganu; Alfred Neequaye
Journal:  Pan Afr Med J       Date:  2014-05-07

Review 7.  Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy.

Authors:  Adnan Bashir Bhatti; Muhammad Usman; Venkataramana Kandi
Journal:  Cureus       Date:  2016-03-01

8.  Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system.

Authors:  Ryosuke Nomura; Takeya Sato; Yuka Sato; Jeffrey A Medin; Shigeki Kushimoto; Teruyuki Yanagisawa
Journal:  Redox Biol       Date:  2017-06-29       Impact factor: 11.799

9.  Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults.

Authors:  Vitus Sambo Badii; Kwame Ohene Buabeng; Thomas Agyarko Poku; Arnold Donkor Forkuo; Bright Boafo Boamah; Stephen Mensah Arhin; Daniel Edem Kpewou
Journal:  Int J Chronic Dis       Date:  2018-04-18

10.  IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity.

Authors:  HariOm Singh; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.